Please select the option that best describes you:
How would you deliver/time radiation for a patient with IIIC1 serous endometrial cancer who is HER2+?
Planning carboplatin/taxol/trastuzumab. Cervical stromal invasion on path. Looking for pelvic vs brachy and timing with chemotherapy.
Answer from: Radiation Oncologist at Academic Institution
Stage III (particularly IIIC) and serous histology are both risk factors for distant failure. In combination, the patient is at an even higher risk. Therefore, I would prioritize getting in all cycles of chemotherapy to maximize distant control; generally, this would comprise 6 cycles of carboplatin...
Sign in or Register to read more